These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 21650161)

  • 1. Systematic enumeration of heteroaromatic ring systems as reagents for use in medicinal chemistry.
    Ward RA; Kettle JG
    J Med Chem; 2011 Jul; 54(13):4670-7. PubMed ID: 21650161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ring systems in mutagenicity databases.
    Kho R; Hodges JA; Hansen MR; Villar HO
    J Med Chem; 2005 Oct; 48(21):6671-8. PubMed ID: 16220983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quest for the rings. In silico exploration of ring universe to identify novel bioactive heteroaromatic scaffolds.
    Ertl P; Jelfs S; Mühlbacher J; Schuffenhauer A; Selzer P
    J Med Chem; 2006 Jul; 49(15):4568-73. PubMed ID: 16854061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combinatorial library design from reagent pharmacophore fingerprints.
    Chen H; Engkvist O; Blomberg N
    Methods Mol Biol; 2011; 685():135-52. PubMed ID: 20981522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioactivity-guided navigation of chemical space.
    Bon RS; Waldmann H
    Acc Chem Res; 2010 Aug; 43(8):1103-14. PubMed ID: 20481515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A practical method for targeted library design balancing lead-like properties with diversity.
    Stocks MJ; Wilden GR; Pairaudeau G; Perry MW; Steele J; Stonehouse JP
    ChemMedChem; 2009 May; 4(5):800-8. PubMed ID: 19360802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods for combinatorial and parallel library design.
    Schnur DM; Beno BR; Tebben AJ; Cavallaro C
    Methods Mol Biol; 2011; 672():387-434. PubMed ID: 20838978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From structure-activity to structure-selectivity relationships: quantitative assessment, selectivity cliffs, and key compounds.
    Peltason L; Hu Y; Bajorath J
    ChemMedChem; 2009 Nov; 4(11):1864-73. PubMed ID: 19750525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug rings database with web interface. A tool for identifying alternative chemical rings in lead discovery programs.
    Lewell XQ; Jones AC; Bruce CL; Harper G; Jones MM; McLay IM; Bradshaw J
    J Med Chem; 2003 Jul; 46(15):3257-74. PubMed ID: 12852756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heteroaromatic rings of the future.
    Pitt WR; Parry DM; Perry BG; Groom CR
    J Med Chem; 2009 May; 52(9):2952-63. PubMed ID: 19348472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current directions in the evolution of compound libraries.
    Webb TR
    Curr Opin Drug Discov Devel; 2005 May; 8(3):303-8. PubMed ID: 15892244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploiting personalized information for reagent selection in drug design.
    Boström J; Falk N; Tyrchan C
    Drug Discov Today; 2011 Mar; 16(5-6):181-7. PubMed ID: 21262382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A collection of robust organic synthesis reactions for in silico molecule design.
    Hartenfeller M; Eberle M; Meier P; Nieto-Oberhuber C; Altmann KH; Schneider G; Jacoby E; Renner S
    J Chem Inf Model; 2011 Dec; 51(12):3093-8. PubMed ID: 22077721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward the comprehensive systematic enumeration and synthesis of novel kinase inhibitors based on a 4-anilinoquinazoline binding mode.
    Kettle JG; Ward RA
    J Chem Inf Model; 2010 Apr; 50(4):525-33. PubMed ID: 20141221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterocyclic Regioisomer Enumeration (HREMS): A Cheminformatics Design Tool.
    Tyagarajan S; Lowden CT; Peng Z; Dykstra KD; Sherer EC; Krska SW
    J Chem Inf Model; 2015 Jun; 55(6):1130-5. PubMed ID: 26017267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Which aspects of HTS are empirically correlated with downstream success?
    Bender A; Bojanic D; Davies JW; Crisman TJ; Mikhailov D; Scheiber J; Jenkins JL; Deng Z; Hill WA; Popov M; Jacoby E; Glick M
    Curr Opin Drug Discov Devel; 2008 May; 11(3):327-37. PubMed ID: 18428086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and Synthesis of Fsp(3)-Rich, Bis-Spirocyclic-Based Compound Libraries for Biological Screening.
    Stotani S; Lorenz C; Winkler M; Medda F; Picazo E; Ortega Martinez R; Karawajczyk A; Sanchez-Quesada J; Giordanetto F
    ACS Comb Sci; 2016 Jun; 18(6):330-6. PubMed ID: 27163646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Property distributions: differences between drugs, natural products, and molecules from combinatorial chemistry.
    Feher M; Schmidt JM
    J Chem Inf Comput Sci; 2003; 43(1):218-27. PubMed ID: 12546556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current parallel chemistry principles and practice: application to the discovery of biologically active molecules.
    Edwards PJ
    Curr Opin Drug Discov Devel; 2009 Nov; 12(6):899-914. PubMed ID: 19894197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small molecule conformational preferences derived from crystal structure data. A medicinal chemistry focused analysis.
    Brameld KA; Kuhn B; Reuter DC; Stahl M
    J Chem Inf Model; 2008 Jan; 48(1):1-24. PubMed ID: 18183967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.